An expert on the weight loss drug Acomplia has recently been expounding his views on its effectiveness and has been explaining exactly how the drug Rimonabant works. Dr. Aronne who is also an authority on weight loss and obesity thinks that the drug is a very useful tool in the fight to beat obesity and feels that it should be given full FDA approval in the United States.

Dr Aronne argues that the way that this drug works is perfect for obese people as in testing it has been seen that many obese people has an overactive endocannabinoid system that means that they get the signal from the stomach to the brain to eat more than they should. He went on to say that people who eat a high fat and a high carbohydrate diet activate the endocannabinoid system more than those people who don’t creating a sort of vicious circle. This could explain one of the reasons why obese people find it so difficult to lose weight and cut down their eating habits.

Acomplia that is to be called Zimulti in the United States works by stopping the message from the brain to eat more to be transmitted to the stomach thus reducing hunger pangs. Acomplia literally turns off your normal appetite so that you do not think about eating all the time and thus you are able to get on with your day without food cravings. The Acomplia drug is fully approved in the UK and has been for the last 7 months and is selling well. It needs a doctor’s prescription and must be taken in conjunction with a sensible healthy diet.

Acomplia is also said to help people attain better levels of blood sugar and increase the good cholesterol in the blood as well as reduce the bad cholesterol. Acomplia can be used by diabetics and has been seen to improve their condition.